Skip to main content
logo
Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
12.88
-0.14 (-1.08%)
At close: Aug 26, 2026, 4:00 PM EDT
12.85
-0.03 (-0.23%)
After-hours: Aug 26, 2026, 7:30 PM EDT

Benitec Biopharma Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
---0.080.070.06
Revenue Growth
---2.74%23.73%-42.16%
Gross Profit
--0.110.080.06-0.06
Operating Income
-46.6-41.77-22.49-19.08-17.85-13.6
Net Income
-41.54-37.92-22.37-19.56-18.21-13.88
Earnings Per Share
-0.93-1.05-1.22-14.12-37.88-54.94
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
184.7697.7450.872.484.0619.77
Total Debt
0.880.850.280.560.810.21
Net Cash (Debt)
183.8996.950.581.923.2519.56
Net Cash Growth
79.18%91.56%2537.23%-41.00%-83.38%108.11%
Net Cash Per Share
4.132.682.751.386.7677.40

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-19.79-23.59-19.4-18.01-15.9-12.83
Capital Expenditures
-0.03-0.02-0.18-0-0.01-0.22
Free Cash Flow
-19.82-23.61-19.58-18.01-15.91-13.05
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
---100.00%87.67%-108.47%
Operating Margin
----25441.33%-24457.53%-23044.07%
Pretax Margin
----26082.67%-24942.47%-23528.81%
Profit Margin
----26082.67%-24942.47%-23528.81%
FCF Margin
----24017.33%-21797.26%-22123.73%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
---88.98129.85565.78